Abstract

Method for inhibiting tau protein aggregation and treatment of Alzheimer's disease, administering a derivative of quinoline having formula (I), where R2 is 2-(4-aminophenyl) or 2-(4-methylphenyl) and R6 is methyl, as inhibitor of tau protein aggregation.